Isomorphic Labs · $2.1B · Unbekannt

Isomorphic Labs, a startup spun out of Google DeepMind that uses AI for drug discovery, has landed a $2.1 billion investment. CEO Demis Hassabis called it a 'massive vote of confidence' in AI-driven drug development. The capital will accelerate research and expand therapeutic pipelines.

AI-generated: summaries written by AI from the linked sources. How we use AI